Laser Treatment for Alopecia

Recruiting in Palo Alto (17 mi)

Age: 18 - 65

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: Lumenis Be Ltd.

No Placebo Group

Trial Summary

What is the purpose of this trial?The study incudes 18 to 55 y/o healthy subjects with moderate hair loss stage and Fitzpatrick skin type 5 or 6

Eligibility Criteria

This trial is for healthy adults aged 21-55 with skin types V to VI who have mild to moderate hair loss. Participants must not have used hair-loss treatments recently, be in good health, and willing to follow study requirements like using non-medicated shampoo and attending all visits.

Inclusion Criteria

My doctor has confirmed I have hair loss or thinning.

In good general health, as determined by the Investigator

Have a negative urine pregnancy test at screening and be using, and continue to use for the duration of the study, an effective contraception method

+12 more

Exclusion Criteria

Use of any products or devices purported to promote scalp hair growth within the 90 days prior to the Baseline Visit

Patient is of skin type I-IV

Subjects who are pregnant, planning to become pregnant or breastfeeding

+16 more

Participant Groups

The FoLix treatment is being tested on individuals with certain types of hair loss. The goal is to see if this fractional non-ablative laser therapy can improve the appearance of scalp hair in those with darker skin tones.

1Treatment groups

Active Control

Group I: healthy subjects with moderate hair loss stage and skin color type 5 or 6Active Control1 Intervention

The FoLix is FDA cleared for hair loss treatments in patients with skin type 1 to 4. It is no being studied for patients with skin type 5 and 6 to allow expending the product labeling